There are devastating conditions that currently offer very few options for families. This is what science has planned.
NovaBridge Biosciences remains a high-risk, catalyst-driven biotech, trading near cash value with a focus on pipeline ...
In 2025, Seres received a non-dilutive award from CARB-X for up to $3.6 million, representing the Company’s second CARB-X award, to support development of an oral liquid formulation based on SER-155 ...
Las Vegas, NV - April 07, 2026 - PRESSADVANTAGE - As organizations operate under accelerating timelines, increasing ...
FasterCapital announced it has selected FuelDash to join EquityPilot supporting the Colorado startup as it prepares to ...
Alignment with the FDA across proposed study parameters of RESTORE, a 16-week registrational study evaluating NVG-291 in chronic tetraplegia. Primary endpoint will be the change from baseline in ...
Nobel laureate Sir Michael Houghton and colleagues at Applied Pharmaceutical Innovation (API) outline how rigorous early ...
Morning Overview on MSN
15-MW microreactor developer makes key filing as deployment plans advance
Oklo Inc., the company behind the 15‑MW Aurora microreactor, has filed its Annual Report on Form 10‑K for the fiscal year ...
This biotech innovator in gastrointestinal and kidney therapies reported a notable insider sale amid routine portfolio ...
Regional Planning & Economic Development in the Northeast Kingdom. David Snedeker, Executive Director [email protected] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results